- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 08.05. | Eisai, Biogen face delay to subcutaneous Leqembi | ||
| 08.05. | J&J seeks to rewrite the script on depression treatment | ||
| 08.05. | Windward raises $165m for TSLP drug, and other biofinancings | ||
| 08.05. | Manufacturing hangover drives Daiichi Sankyo into the red | ||
| 07.05. | Bayer plans filings for cardiac amyloidosis imaging agent | ||
| 07.05. | Roche buys AI-powered diagnostics player PathAI | ||
| 07.05. | Mike Guarino appointed to lead EVERSANA INTOUCH | ||
| 07.05. | Angelini seeks US beachhead with $4.1bn Catalyst buy | ||
| 06.05. | Lilly inflates US facility investment spending by $4.5bn | ||
| 06.05. | CellCentric pockets $220m for blood cancer programme | ||
| 06.05. | BioNTech winds down COVID jab manufacturing, shedding staff | ||
| 06.05. | GSK bolts on siRNA drug from China's SiranBio in $1bn deal | ||
| 06.05. | Bayer returns to M&A with $2.45bn Perfuse Therapeutics deal | ||
| 06.05. | Novo Nordisk buoyed by outperforming oral Wegovy in Q1 | ||
| 05.05. | After rival fails, Cytokinetics could broaden Myqorzo label | ||
| 05.05. | AI-powered study finds multiple Parkinson's types | ||
| 05.05. | UK's Cytospire draws in $83m for new T-cell engager platform | ||
| 05.05. | 'Seismic shift' as obesity overtakes cancer for R&D returns | ||
| 05.05. | Autoimmune disease biotech Odyssey sets terms for $225m IPO | ||
| 04.05. | UCB buys cell therapy biotech Candid for $2bn upfront | ||
| 04.05. | Pfizer, Arvinas join SERD club with Veppanu approval | ||
| 01.05. | Moderna's Q1 revenues rocket, thanks to ex-US sales | ||
| 01.05. | FDA's ODAC delivers one loss, one win for AstraZeneca | ||
| 01.05. | Axsome breaks new ground in Alzheimer's with Auvelity OK | ||
| 30.04. | Parexel buys Vitrana to boost patient safety toolkit |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.